Loading...
Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma.
Lim, Kok Haw Jonathan Spain, L Barker, C Georgiou, A Walls, G Gore, M Turajlic, S Board, R Larkin, J Lorigan, Paul C
Lim, Kok Haw Jonathan
Spain, L
Barker, C
Georgiou, A
Walls, G
Gore, M
Turajlic, S
Board, R
Larkin, J
Lorigan, Paul C
Citations
Altmetric:
Abstract
Agreement on the utility of imaging follow-up in patients with high-risk melanoma is lacking. A UK consensus statement recommends a surveillance schedule of CT or positron-emission tomography-CT and MRI brain (every 6 months for 3 years, then annually in years 4 and 5) as well as clinical examination for high-risk resected Stages II and III cutaneous melanoma. Our aim was to assess patterns of relapse and whether imaging surveillance could be of clinical benefit.
Description
Date
2018
Publisher
Collections
Files
Keywords
Type
Article
Citation
Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma. 2018, 3(2): e000317 ESMO Open